查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
北美生物反应器市场预测至 2030 年 - 区域分析 - 按规模、应用、技术和最终用户
市场调查报告书
商品编码
1533045

北美生物反应器市场预测至 2030 年 - 区域分析 - 按规模、应用、技术和最终用户

North America Bioreactors Market Forecast to 2030 - Regional Analysis - by Scale, Application, Technology, and End User
出版日期: | 出版商: The Insight Partners | 英文 76 Pages | 订单完成后即时交付

价格

2022年北美生物反应器市值为15.756亿美元，预计到2030年将达到26.690亿美元；预计2022年至2030年复合年增长率为6.8%。

越来越多地采用一次性生物反应器推动北美生物反应器市场

许多製造商正在开发一次性生物反应器 (SUB)，因为它们坚固耐用，并提供生物製药商业製造所需的高性能。薄膜技术、搅拌机制、生物反应器设计和感测器系统等优势有助于提高一次性反应器从实验室到生产规模的采用。一次性生物反应器提供下一代细胞和基因疗法以及连续生物加工。细胞培养过程的进步已经产生了更高的滴度和细胞密度，这促进了 SUB 的采用。

一次性生物反应器可降低污染风险并缩短生产週转时间。在过去几年中，一次性生物反应器在现代生物製药製程中的使用有所增加，因为它们具有增强灵活性、减少投资和限制营运成本的独特能力。此外，许多公司还开发了一次性生物反应器来生产各种治疗药物。例如，2021 年 3 月，Thermo Fischer Scientific 推出了 3,000 L 和 5,000 L HyPerforma DynaDrive 一次性生物反应器。

缩短验证时间是一次性生物反应器的基本优势之一。上游生物加工越来越多地采用一次性生物反应器正在推动市场成长。例如，Sartorius AG 提供各种一次性生物反应器。该公司提供适用于 10-15 mL 微型生物反应器规模的 ambr 15 和适用于 50-2000L 规模的 Biostat STR。人们越来越接受一次性生物反应器用于生产治疗药物，这正在推动生物反应器市场的发展。

北美生物反应器市场概况

美国是生物反应器的最大市场——美国的一些市场参与者为製药和生物技术公司的各种应用製造生物反应器。新生物反应器的推出、地理扩张以及市场参与者的合作伙伴关係推动了市场的成长。 2023 年 4 月，BioMADE 宣布了五个新项目，重点是透过推进生物反应器技术来解决美国生物工业製造的研究和采用差距。这些项目的资金承诺为 1050 万美元，涵盖工程、硬体开发和可扩展性，以解决加速强劲经济的障碍。这些项目专注于创新，并将在施密特期货的支持下推进生物反应器的设计和开发。 2023 年 4 月，Cytiva 推出了 X 平台生物反应器，以一次性产品简化上游生物加工作业。最初，生物反应器的可用尺寸为 50 公升和 200 公升。然而，X-Platform 生物反应器配备了 Figurate 自动化解决方案软体，可透过人体工学改进、生产能力和简化供应链操作来提高製程效率。

北美生物反应器市场收入及 2030 年预测（百万美元）

北美生物反应器市场细分

北美生物反应器市场根据规模、应用、技术、最终用户和国家进行细分。根据规模，北美生物反应器市场分为实验室规模生产、中试规模生产和大规模生产。 2022年，中试规模生产领域占最大的市场占有率。

在应用方面，北美生物反应器市场分为微生物应用、细胞培养应用等。 2022年，细胞培养应用领域占据最大的市场份额。

依技术划分，北美生物反应器市场分为补料生物反应器和灌流生物反应器。补料式生物反应器领域在 2022 年将占据更大的市场份额。

根据最终用户，北美生物反应器市场分为生物製药製造商、研发组织和合约製造组织。 2022 年，研发组织部门占据最大的市场份额。

根据国家/地区，北美生物反应器市场分为美国、加拿大和墨西哥。 2022年，美国在北美生物反应器市场份额中占据主导地位。

PBS Biotech Inc、通用电气公司、默克、Thermo Fisher Scientific Inc、Sartorius AG、颇尔公司、Solaris Biotechnology SRL 和 Applikon Biotechnology BV 是北美生物反应器市场的一些领先参与者。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美生物反应器市场 - 主要产业动态

  • 生物反应器市场 - 主要产业动态
  • 市场驱动因素
    • 越来越多地采用一次性生物反应器
    • 医药及生技产业快速成长
  • 市场限制
    • 严格的规范架构
  • 市场机会
    • 对个人化医疗的需求不断增长
  • 未来趋势
    • 生物反应器的技术进步
  • 驱动因素和限制的影响：

第 5 章：生物反应器市场 - 北美市场分析

  • 概述
  • 生物反应器市场收入，2020 - 2030

第 6 章：北美生物反应器市场分析 - 规模

  • 概述
  • 2022 年和 2030 年生物反应器市场收入份额（按规模）
  • 实验室规模生产
    • 概述
    • 实验室规模生产市场、收入与 2030 年预测
  • 中试规模生产
    • 概述
    • 中试规模生产市场、收入与 2030 年预测
  • 全面製作
    • 概述
    • 全面生产市场、收入和 2030 年预测

第 7 章：北美生物反应器市场分析 - 应用

  • 概述
  • 2022 年和 2030 年按应用分類的生物反应器市场收入份额 (%)
  • 微生物应用
    • 概述
    • 微生物应用市场、收入与 2030 年预测
  • 细胞培养应用
    • 概述
    • 细胞培养应用市场、收入及2030年预测
  • 其他的
    • 概述
    • 其他市场、收入和 2030 年预测

第 8 章：北美生物反应器市场分析 - 技术

  • 概述
  • 2022 年和 2030 年按技术分類的生物反应器市场收入份额 (%)
  • 补料分批生物反应器
    • 概述
    • 补料分批生物反应器市场、收入和 2030 年预测
  • 灌註生物反应器
    • 概述
    • 灌註生物反应器市场、收入和 2030 年预测

第 9 章：北美生物反应器市场分析 - 最终用户

  • 概述
  • 2022 年和 2030 年按最终用户分類的生物反应器市场收入份额 (%)
  • 生物製药製造商
    • 概述
    • 生物製药製造商市场、收入和 2030 年预测
  • 研究与开发组织
    • 概述
    • 研究与开发组织市场、收入和 2030 年预测
  • 合约製造组织
    • 概述
    • 合约製造组织市场、收入和 2030 年预测

第 10 章：北美生物反应器市场 - 按国家分析

  • 北美洲

第 11 章：生物反应器市场-产业格局

  • 概述
  • 生物反应器市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 12 章：公司简介

  • PBS Biotech Inc
  • General Electric Co
  • Merck KGaA
  • Thermo Fisher Scientific Inc
  • Sartorius AG
  • Pall Corp
  • Solaris Biotechnology SRL
  • Applikon Biotechnology BV

第 13 章：附录

Product Code: TIPRE00011475

The North America bioreactors market was valued at US$ 1,575.60 million in 2022 and is expected to reach US$ 2,669.00 million by 2030; it is estimated to grow at a CAGR of 6.8% from 2022 to 2030 .

Increasing Adoption of Single-Use Bioreactors Fuels North America Bioreactors Market

Various manufacturers are developing single-use bioreactors (SUBs) as they are robust and provide the high performance required for commercial manufacturing of biopharmaceuticals. Advantages such as film technologies, stirring mechanisms, bioreactor designs, and sensor systems have contributed toward increasing the adoption of disposable reactors from the lab to the production scale. The single-use bioreactors provide next-generation cell and gene therapies and continuous bioprocessing. The advancements in cell-culture processes have developed higher titers and cell densities, which have facilitated the adoption of SUBs.

Single-use bioreactors reduce the risks of contamination and decrease production turnaround times. In the last few years, the use of single-use bioreactors has increased in modern biopharmaceutical processes owing to their unique ability to enhance flexibility, reduce investment, and limit operational costs. Also, many companies have developed single-use bioreactors for producing a wide range of therapeutics. For instance, in March 2021, Thermo Fischer Scientific launched the 3,000 L and 5,000 L HyPerforma DynaDrive single-use bioreactors.

The reduction in validation time has been one of the essential benefits of single-use bioreactors. The rising adoption of single-use bioreactors for upstream bioprocessing is driving the market growth. For instance, Sartorius AG offers a wide range of single-use bioreactors. The company provides ambr 15 for a 10-15 mL micro bioreactor scale and Biostat STR for 50-2000L. The increasing acceptance of single-use bioreactors for the production of therapeutics is driving the market for bioreactors.

North America Bioreactors Market Overview

The US is the largest market for bioreactors-several market players in the US manufacture bioreactors for various applications in pharmaceutical and biotechnology companies. Launch of new bioreactors, geographical expansion, and partnerships by market players drive the growth of the market. In April 2023, BioMADE announced five new projects focused on addressing the research and adoption gaps in bioindustrial manufacturing in the US by advancing bioreactor technology. With a funding commitment of US$ 10.5 million, these projects would span engineering, hardware development, and scalability to address the barriers to accelerate a robust economy. These projects focus on innovation and will advance the design and development of bioreactors, supported by Schmidt Futures. In April 2023, Cytiva launched X-platform bioreactors to simplify upstream bioprocessing operations with single-use products. Initially, available sizes of bioreactors were 50 and 200L. However, the X-Platform bioreactors are equipped with Figurate automation solution software and can increase process efficiency through ergonomic improvements, production capacity, and simplified supply chain operations.

North America Bioreactors Market Revenue and Forecast to 2030 (US$ Million)

North America Bioreactors Market Segmentation

The North America bioreactors market is segmented based on scale, application, technology, end user, and country. Based on scale, the North America bioreactors market is segmented into lab-scale production, pilot-scale production, and full-scale production. The pilot-scale production segment held the largest market share in 2022.

In terms of application, the North America bioreactors market is segmented into microbial application, cell culture application, and others. The cell culture application segment held the largest market share in 2022.

By technology, the North America bioreactors market is bifurcated into fed-batch bioreactors and perfusion bioreactors. The fed-batch bioreactors segment held a larger market share in 2022.

Based on end user, the North America bioreactors market is categorized into biopharma manufacturers, research and development organizations, and contract manufacturing organization. The research and development organizations segment held the largest market share in 2022.

Based on country, the North America bioreactors market is segmented into the US, Canada, and Mexico. The US dominated the North America bioreactors market share in 2022.

PBS Biotech Inc, General Electric Co, Merck KGaA, Thermo Fisher Scientific Inc, Sartorius AG, Pall Corp, Solaris Biotechnology SRL, and Applikon Biotechnology BV are some of the leading players operating in the North America bioreactors market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Bioreactors Market - Key Industry Dynamics

  • 4.1 Bioreactors Market - Key Industry Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Increasing Adoption of Single-Use Bioreactors
    • 4.2.2 Rapid Growth of Pharmaceutical and Biotechnology Industry
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Framework
  • 4.4 Market Opportunities
    • 4.4.1 Rising Demand for Personalized Medicine
  • 4.5 Future Trends
    • 4.5.1 Technological Advancements in Bioreactors
  • 4.6 Impact of Drivers and Restraints:

5. Bioreactors Market - North America Market Analysis

  • 5.1 Overview
  • 5.2 Bioreactors Market Revenue (US$ Million), 2020 - 2030

6. North America Bioreactors Market Analysis - Scale

  • 6.1 Overview
  • 6.2 Bioreactors Market Revenue Share, by Scale 2022 & 2030 (%)
  • 6.3 Lab-Scale Production
    • 6.3.1 Overview
    • 6.3.2 Lab-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Pilot-Scale Production
    • 6.4.1 Overview
    • 6.4.2 Pilot-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Full-Scale Productions
    • 6.5.1 Overview
    • 6.5.2 Full-Scale Production Market, Revenue and Forecast to 2030 (US$ Million)

7. North America Bioreactors Market Analysis - Application

  • 7.1 Overview
  • 7.2 Bioreactors Market Revenue Share, by Application 2022 & 2030 (%)
  • 7.3 Microbial Application
    • 7.3.1 Overview
    • 7.3.2 Microbial Application Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Cell Culture Application
    • 7.4.1 Overview
    • 7.4.2 Cell Culture Application Market, Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

8. North America Bioreactors Market Analysis - Technology

  • 8.1 Overview
  • 8.2 Bioreactors Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Fed-Batch Bioreactors
    • 8.3.1 Overview
    • 8.3.2 Fed-Batch Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Perfusion Bioreactors
    • 8.4.1 Overview
    • 8.4.2 Perfusion Bioreactors Market, Revenue and Forecast to 2030 (US$ Million)

9. North America Bioreactors Market Analysis - End User

  • 9.1 Overview
  • 9.2 Bioreactors Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Biopharma Manufacturers
    • 9.3.1 Overview
    • 9.3.2 Biopharma Manufacturers Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Research and Development Organizations
    • 9.4.1 Overview
    • 9.4.2 Research and Development Organizations Market, Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Contract Manufacturing Organization
    • 9.5.1 Overview
    • 9.5.2 Contract Manufacturing Organization Market, Revenue and Forecast to 2030 (US$ Million)

10. North America Bioreactors Market - by Country Analysis

  • 10.1 North America: Bioreactors Market
    • 10.1.1 North America Bioreactors Market Revenue and Forecasts and Analysis - By Country
      • 10.1.1.1 United States
      • 10.1.1.2 Overview
      • 10.1.1.3 US: Bioreactors Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 United States Bioreactors Market Breakdown by Scale
        • 10.1.1.3.2 United States Bioreactors Market Breakdown by Application
        • 10.1.1.3.3 United States Bioreactors Market Breakdown by Technology
        • 10.1.1.3.4 United States Bioreactors Market Breakdown by End User
      • 10.1.1.4 Canada
      • 10.1.1.5 Overview
      • 10.1.1.6 Canada: Bioreactors Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 Canada Bioreactors Market Breakdown by Scale
        • 10.1.1.6.2 Canada Bioreactors Market Breakdown by Application
        • 10.1.1.6.3 Canada Bioreactors Market Breakdown by Technology
        • 10.1.1.6.4 Canada Bioreactors Market Breakdown by End User
      • 10.1.1.7 Mexico
      • 10.1.1.8 Overview
      • 10.1.1.9 Mexico: Bioreactors Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.9.1 Mexico Bioreactors Market Breakdown by Scale
        • 10.1.1.9.2 Mexico Bioreactors Market Breakdown by Application
        • 10.1.1.9.3 Mexico Bioreactors Market Breakdown by Technology
        • 10.1.1.9.4 Mexico Bioreactors Market Breakdown by End User

11. Bioreactors Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Bioreactors Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 PBS Biotech Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 General Electric Co
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Merck KGaA
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Thermo Fisher Scientific Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Sartorius AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Pall Corp
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Solaris Biotechnology SRL
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Applikon Biotechnology BV
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Bioreactors Market Segmentation
  • Table 2. United States Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Scale
  • Table 3. United States Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Application
  • Table 4. United States Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Technology
  • Table 5. United States Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
  • Table 6. Canada Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Scale
  • Table 7. Canada Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Application
  • Table 8. Canada Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Technology
  • Table 9. Canada Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
  • Table 10. Mexico Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Scale
  • Table 11. Mexico Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Application
  • Table 12. Mexico Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By Technology
  • Table 13. Mexico Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn) - By End User
  • Table 14. Recent Inorganic Growth Strategies in the Bioreactors Market
  • Table 15. Recent Organic Growth Strategies in the Bioreactors Market
  • Table 16. Glossary of Terms, Bioreactors Market

List Of Figures

  • Figure 1. Bioreactors Market Segmentation, By Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Bioreactors Market Revenue (US$ Million), 2020 - 2030
  • Figure 4. Bioreactors Market Revenue Share, by Scale 2022 & 2030 (%)
  • Figure 5. Lab-Scale Production Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 6. Pilot-Scale Production Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 7. Full-Scale Production Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 8. Bioreactors Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 9. Microbial Application Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 10. Cell Culture Application Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 11. Others Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 12. Bioreactors Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 13. Fed-Batch Bioreactors Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 14. Perfusion Bioreactors Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 15. Bioreactors Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 16. Biopharma Manufacturers Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 17. Research and Development Organizations Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 18. Contract Manufacturing Organization Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 19. North America: Bioreactors Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 20. North America Bioreactors Market Breakdown by Key Countries, 2022 and 2030 (%)
  • Figure 21. United States Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 22. Canada Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 23. Mexico Bioreactors Market Revenue and Forecasts to 2030 (US$ Mn)
  • Figure 24. Growth Strategies in the Bioreactors Market